1 Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis
来源:EUR RESPIR J( P 0903-1936 E 1399-3003 ) 发表时间: 2020/05
类型:期刊论文 为本人加分:8135.271416
贡献度:共同第一作者
2 Efficacy and safety of first line treatments for patients with advanced epidermal growth factor rece..
来源:BMJ-BRIT MED J( P 0959-535X E 1756-1833 ) 发表时间: 2019/10
类型:期刊论文 为本人加分:3445.672787
贡献度:单独第一作者
3 The Optimal Treatment for Stage IIIA-N2 Non-Small Cell Lung Cancer: A Network Meta-Analysis
来源:ANN THORAC SURG( P 0003-4975 E 1552-6259 ) 发表时间: 2019/06
类型:期刊论文 为本人加分:1201.453352
4 Toxicity profile of epidermal growth factor receptor tyrosine kinase inhibitors for patients with lu..
来源:CRIT REV ONCOL HEMAT( P 1040-8428 E 1879-0461 ) 发表时间: 2021/04
类型:期刊论文 为本人加分:677.021346
贡献度:共同第一作者
5 Liquid biopsy for early stage lung cancer
来源:J THORAC DIS( P 2072-1439 E 2077-6624 ) 发表时间: 2018/04
类型:期刊论文 为本人加分:470.213678
6 PD-L1 expression and Tumor mutation burden as Pathological response biomarkers of Neoadjuvant immuno..
来源:CRIT REV ONCOL HEMAT( P 1040-8428 E 1879-0461 ) 发表时间: 2022/02
类型:期刊论文 为本人加分:357.501122
贡献度:共同第一作者
7 Personal protective equipment protecting healthcare workers in the Chinese epicentre of COVID-19
来源:CLIN MICROBIOL INFEC( P 1198-743X E 1469-0691 ) 发表时间: 2020/12
类型:期刊论文 为本人加分:159.599600
8 Development and Validation of a Clinical Risk Score to Predict the Occurrence of Critical Illness in..
来源:JAMA INTERN MED( P 2168-6106 E 2168-6114 ) 发表时间: 2020/08
类型:期刊论文 为本人加分:128.139527
贡献度:参与作者
9 Predicting EGFR mutation status in lung adenocarcinoma presenting as ground-glass opacity: utilizing..
来源:EUR RADIOL( P 0938-7994 E 1432-1084 ) 发表时间: 2022/09
类型:期刊论文 为本人加分:55.344808
贡献度:共同第一作者
10 The impact of postoperative EGFR-TKIs treatment on residual GGO lesions after resection for lung can..
来源:SIGNAL TRANSDUCT TAR( P 2095-9907 E 2059-3635 ) 发表时间: 2021/02
类型:期刊论文 为本人加分:45.943085